Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 05:00PM GMT
Release Date Price: $19.11 (-1.19%)
Steven Couche
Jefferies LLC, Research Division - Equity Associate

Welcome to the 2022 Jefferies Healthcare Conference. My name is Steven Couche. I'm filling in for Dave Windley, who is currently in quarantine trying to get a negative PCR test, so he can join us. I'm happy to be joined by the Certara team, William Feehery, CEO; and Andy Schemick, CFO. Thank you for being here.

Questions & Answers

Steven Couche
Jefferies LLC, Research Division - Equity Associate

So I guess we will jump right into it. Certara went public in December 2020. So a lot of questions we still get are around the industry in understanding biosimulation, which is roughly 2/3, maybe 70% of your business and then the additional 30-or-so percent is direct services with some market access.

If we think about the overall clinical development industry being 6%, 7%, 8%, but biosim being mid-teens. Maybe at the industry level, can you help us bridge that growth gap.

William F. Feehery
Certara, Inc. - CEO & Director

Yes. So

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot